Free Trial
Final Hours! Save $100 on MarketBeat All Access Before 11:59 PM
  • 0Days
  • 0Hours
  • 0Minutes
  • 0Seconds
Lock In $149 Tonight
Claim MarketBeat All Access Sale Promotion

BeOne Medicines (ONC) Earnings Date, Estimates & Call Transcripts

BeOne Medicines logo
$310.25 0.00 (0.00%)
Closing price 05/22/2026 04:00 PM Eastern
Extended Trading
$305.65 -4.60 (-1.48%)
As of 05/22/2026 06:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

BeOne Medicines Earnings Summary

BeOne Medicines released Q1 2026 earnings on April 1, 2026, reporting an EPS of $0.25. Quarterly revenue was reported to be $1.51 billion. With a trailing EPS of $4.47 and a P/E Ratio of 69.41, BeOne Medicines' earnings are expected to grow 83.54% next year, from $5.65 to $10.37 per share.

Q1 2026 Earnings Resources

Latest Q1 2026
Earnings Date
Apr. 1Confirmed
Actual Revenue
(Apr. 1)
$1.51B
Get BeOne Medicines Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on BeOne Medicines and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

ONC Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ONC Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BeOne Medicines Analyst EPS Estimates

Current Year EPS Consensus Estimate
$5.65 EPS
Next Year EPS Consensus Estimate
$10.37 EPS

BeOne Medicines Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
4/1/2026Q1 2026-$0.25-$1.95-$1.51B
2/26/2026Q4 2025$1.60$0.58 -$1.02$0.58$1.45B$1.50B
8/6/2025Q2 2025$0.48$0.84+$0.36$0.84$1.24B$1.32B
5/7/2025Q1 2025-$0.71$1.22+$1.93$0.01$1.12B$1.12B
2/27/2025Q4 2024-$0.88-$1.43 -$0.55-$1.43$1.09B$1.13B

Data powered by Fiscal.ai.

BeOne Medicines Earnings - Frequently Asked Questions

BeOne Medicines (NASDAQ:ONC) last announced its quarterly earning data on Wednesday, April 1, 2026. Learn more on ONC's earnings history.

BeOne Medicines issued an update on its FY 2026 earnings guidance on Wednesday, May, 6th. The company issued revenue guidance of $6.3 billion-$6.5 billion, compared to the consensus revenue estimate of $6.4 billion.

BeOne Medicines (NASDAQ:ONC) has a recorded annual revenue of $5.34 billion.

BeOne Medicines (NASDAQ:ONC) has a recorded net income of $286.93 million. ONC has generated $4.47 earnings per share over the last four quarters.

BeOne Medicines (NASDAQ:ONC) has a trailing price-to-earnings ratio of 69.41 and a forward price-to-earnings ratio of 54.91.

BeOne Medicines' earnings are expected to grow from $5.65 per share to $10.37 per share in the next year, which is a 83.54% increase.

Related Companies
Earnings Tools

This page (NASDAQ:ONC) was last updated on 5/25/2026 by MarketBeat.com Staff.
From Our Partners
I was right about SpaceX
Jeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...
Profits Run | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
SpaceX IPO hides a much bigger story
The SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...
Weiss Ratings | Sponsoredtc pixel
Read now. Do not delete. You’ve been warned.
Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” P...
Porter & Company | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel